These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 8088931)
1. Methylxanthine drug therapy in chronic heart failure associated with hypoxaemia: double-blind placebo-controlled clinical trial of doxofylline versus theophylline and bamifylline. Dini FL; Pasini G; Cortellini G; Cani E; Bettini R; Garagnani A; Gobbi G; Greco A; Onorato G; Pasini P Int J Clin Pharmacol Res; 1993; 13(6):305-16. PubMed ID: 8088931 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial. Goldstein MF; Chervinsky P Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074 [TBL] [Abstract][Full Text] [Related]
3. Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial. Melillo G; Balzano G; Jodice F; De Felice A; Campisi V; Capone M; Di Filippo A; Foddai G; Franzone JS; Grossi E Int J Clin Pharmacol Res; 1989; 9(6):397-405. PubMed ID: 2699466 [TBL] [Abstract][Full Text] [Related]
4. Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2). Calzetta L; Hanania NA; Dini FL; Goldstein MF; Fairweather WR; Howard WW; Cazzola M Pulm Pharmacol Ther; 2018 Dec; 53():20-26. PubMed ID: 30219705 [TBL] [Abstract][Full Text] [Related]
5. The effects of doxofylline versus theophylline on sleep architecture in COPD patients. Sacco C; Braghiroli A; Grossi E; Donner CF Monaldi Arch Chest Dis; 1995 Apr; 50(2):98-103. PubMed ID: 7613555 [TBL] [Abstract][Full Text] [Related]
6. Treatment of moderate chronic obstructive pulmonary disease (stable) with doxofylline compared with slow release theophylline--a multicentre trial. Santra CK J Indian Med Assoc; 2008 Dec; 106(12):791-2, 794. PubMed ID: 19370950 [TBL] [Abstract][Full Text] [Related]
7. [Heart rhythm changes in patients with chronic obstructive bronchopneumopathies: effects of different methylxanthine drugs]. Cipri A; Pozzar F; Dini FL Minerva Cardioangiol; 1992; 40(1-2):31-9. PubMed ID: 1630668 [TBL] [Abstract][Full Text] [Related]
8. Comparison of intravenously administered doxofylline and placebo for the treatment of severe acute airways obstruction. Dolcetti A; Osella D; De Filippis G; Carnuccio C; Grossi E J Int Med Res; 1988; 16(4):264-9. PubMed ID: 3169372 [TBL] [Abstract][Full Text] [Related]
9. Doxofylline, an adenosine-nonblocking xanthine, does not induce cardiostimulant effects. Cirillo R; Grossi E; Franzone JS Res Commun Chem Pathol Pharmacol; 1989 Jul; 65(1):21-34. PubMed ID: 2781149 [TBL] [Abstract][Full Text] [Related]
10. Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease. Shukla D; Chakraborty S; Singh S; Mishra B Expert Opin Pharmacother; 2009 Oct; 10(14):2343-56. PubMed ID: 19678793 [TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of doxofylline sachets in a pediatric population]. Bagnato G; Fodale P; Bottari M Riv Eur Sci Med Farmacol; 1989 Aug; 11(4):359-63. PubMed ID: 2701030 [TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. Murciano D; Auclair MH; Pariente R; Aubier M N Engl J Med; 1989 Jun; 320(23):1521-5. PubMed ID: 2498658 [TBL] [Abstract][Full Text] [Related]
13. [Comparative effects of bamifylline and theophylline on allergenic bronchospasm induced by the provocative inhalation test : double-blind cross-over study]. Kofman J; Grosclaude M; Ouechni MM; Perrin-Fayolle M Poumon Coeur; 1982; 38(3):197-202. PubMed ID: 6752929 [TBL] [Abstract][Full Text] [Related]
14. [Effects of theophylline and doxofylline on airway responsiveness in beagles]. Sugeta A; Imai T; Idaira K; Horikoshi S; Okamoto M; Adachi M Arerugi; 1997 Jan; 46(1):7-15. PubMed ID: 9078607 [TBL] [Abstract][Full Text] [Related]
15. Lack of cardiostimulant effects of bamifylline in in vitro and in vivo models. Bongrani S; Razzetti R; Papotti M; Pastore F; Bergamaschi M Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):169-74. PubMed ID: 2334457 [TBL] [Abstract][Full Text] [Related]
16. The effect of doxofylline in asthma and COPD. Cazzola M; Matera MG Respir Med; 2020 Apr; 164():105904. PubMed ID: 32094104 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis. Rogliani P; Calzetta L; Ora J; Cazzola M; Matera MG Multidiscip Respir Med; 2019; 14():25. PubMed ID: 31388422 [TBL] [Abstract][Full Text] [Related]
18. Comparative study of the efficacy and safety of theophylline and doxofylline in patients with bronchial asthma and chronic obstructive pulmonary disease. Lal D; Manocha S; Ray A; Vijayan VK; Kumar R J Basic Clin Physiol Pharmacol; 2015 Sep; 26(5):443-51. PubMed ID: 25894641 [TBL] [Abstract][Full Text] [Related]
19. A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study. Calzetta L; Matera MG; Goldstein MF; Fairweather WR; Howard WW; Cazzola M; Rogliani P Pulm Pharmacol Ther; 2020 Feb; 60():101883. PubMed ID: 31884206 [TBL] [Abstract][Full Text] [Related]
20. [Meta-analysis of efficacy and safety of oral theophylline in chronic obstructive pulmonary disease]. Wang CH; Zhang Q; Li M; Fu PF; Yan ZM; Peng AM; Zhang GL Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(8):540-6. PubMed ID: 20367966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]